Non-coding RNAs in Endocrinology (ncRNAs Endocrinol) is the world's first peer-reviewed specialty journal in this emerging area of biology. The journal presents technological advances in the field on the basis of their novelty, importance to other researchers, elegance and surprising conclusions. The journal offers a continuous publication platform, which means no more waiting for articles to be allocated to specific issues. The category of articles that are published range from but are not limited to original research, reviews, perspectives / commentaries on other published research, methodologies, images in ncRNA world as well as commercial technological reports. The Journal Editor is committed to prompt publication of significant advances in this area of biology and to provide a forum for reporting and discussing your views.
Why subscribe and read
Non-coding RNAs in Endocrinology (ncRNAs Endocrinol) is the world's first peer-reviewed specialty journal in this emerging area of biology. The journal presents technological advances in ncRNA discoveries with specific reference to diabetes, obesity and cardiovascular complications as well as other areas of endocrine biology. Articles are chosen on the basis of their novelty, importance to other researchers, elegance and surprising conclusions. The journal offers a continuous publication platform, which means no more waiting for articles to be allocated to specific issues. The category of articles that are published range from but are not limited to original research, reviews, perspectives / commentaries on other published research, methodologies, images in ncRNA world as well as commercial technological reports. The Journal Editor is committed to prompt publication of significant advances in this area of biology and to provide a forum for reporting and discussing your views.
Non-coding RNAs in Endocrinology is a first specialty journal presenting interesting and notable findings from non-coding RNA biology in endocrine disease. Although the major focus of the journal will be to present research and views on ncRNAs in adiposity, diabetes and its complications, the journal also welcomes articles presenting the role of ncRNAs in other endocrine diseases. Considering the increasing prevalence of diabetes and obesity all over the world, this is an apt addition to the scientific community. The journal editors are committed to transparent, comprehensive and rapid reviewing of manuscripts. Excellent editorial staff support provides the opportunity to all authors for a fast review process wherein the first response would be generally between 2 to 4 weeks of submission. All manuscripts are submitted online through the manuscript submission system and are guaranteed immediate attention. All accepted manuscripts are corrected for language suitability by our highly trained language editors. Lastly, the journal offers a unique publishing concept that there are no journal issues. This means less waiting time for accepted articles from being allocated to specific issues.
All of this presents ncRNAs Endocrinol as a unique platform for authors to submit, publish and share their work to the scientific community.
Abstracting & Indexing
Non-coding RNAs in Endocrinology is covered by the following services:
CNKI Scholar (China National Knowledge Infrastructure)
CNPIEC - cnpLINKer
EBSCO (relevant databases)
EBSCO Discovery Service
KESLI-NDSL (Korean National Discovery for Science Leaders)
contain original work - not published elsewhere in any medium (in the whole or in part) by the authors or anyone else and not under consideration for publication in any other medium;
focus on the aims and scope of the journal;
be clearly and correctly written - should contain all essential features of a scientific publication that is easy to understand for the target audience;
written in English - attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper;
be delivered in electronic format.
The journal accepts the following publication formats:
Communications and Rapid Communications
Reviews and Mini-Reviews
Letters to the Editor and Amendments
It is important that authors include a cover letter with their manuscript. Please explain why you consider your manuscript as suitable for publication in the journal, why will your paper inspire the other members of your field, and how will it drive research forward. The letter should contain all important details such as:
your full name (submitted by)
full title of article and short title
full list of authors with affiliations
e-mail of the corresponding author
contact address, telephone/fax numbers of the corresponding author
number of attached files, if there is more than one
status: new, reviewed or accepted (with reference ID if reviewed or accepted)
Cover letter should explicitly state that the manuscript (or one with substantially the same content, by any of the authors) has not been previously published in any language anywhere and that it is not under simultaneous consideration or in press by another journal. If related work has been submitted, then we may require a preprint to be made available. Reviewers will be asked to comment on the overlap between the related submissions.
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, may be resubmitted if the major criticisms have been addressed. The cover letter must state that the manuscript is a resubmission, and the former manuscript number should be provided.
Conflict of interest declaration To ensure fair and objective decision-making, authors must declare any associations that pose a conflict of interest in connection with evaluated manuscripts (see Editorial Policy for details). Authors are encouraged to fill in the ICMJE Conflicts of Interest Form (available here) and send it in the electronic format to the Journal Editor.
Open Access License Authors have to sign an Open Access License that is available on the journal webpage. We encourage the authors to send the signed license along with the manuscript. Please note, that no article will be published unless the Open Access License is signed.
Formatting Requirements We accept submission of text, tables and figures as separate files or as a composite file. For your initial submission, we recommend you upload your entire manuscript, including tables and figures, as a single PDF file. If you are invited to submit a revised manuscript, please provide us with individual files: an editable text and publication-quality figures.
Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH TEXT FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below)
Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted manuscripts, see below). Please note that a straight Excel file is not an acceptable format
Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or PDF. Please note that Powerpoint files are not accepted
Post acceptance, text files of the revised manuscript and tables are required for use in the production.
Authors should clearly indicate location of tables and figures in the text if these elements are given separately or at the end of the manuscript. If this information is not provided to the editorial office, we will assume that they should be left at the end of the text.
For further instructions, please carefully follow the guidelines described in Instructions for Authors.
Journal Editor Anandwardhan A. Hardikar, The University of Sydney, Sydney, Australia
Associate Editor Praveen Sethupathy, UNC Chapel Hill, USA Xiaoqing Tang, Michigan Technological University, USA
Editorial Advisory Board Subrata Chakrabarti, University of Western Ontario, Canada Mark Chong, Walter and Eliza Hall Institute Biotechnology Centre, Australia Mark Cooper, Baker IDI Heart and Diabetes Institute, Australia Maria Craig, University of New South Wales, Australia Costanza Emanueli, University of Bristol, Great Britain Alicia Jenkins, University of Oklahoma, USA Philip Kantharidis, Baker IDI Heart and Diabetes Institute, Australia Ullas Kolthur, Tata Institute of Fundamental Research, India Francis C. Lynn, University of British Columbia, Canada Kasey C. Vickers, National Heart, Lung and Blood Institute, NIH, USA Michael Walker, Weizmann Institute, Israel
Assistant Editors Mugdha Joglekar, University of Sydney, Australia Sarang Satoor, NHMRC Clinical Trials Centre, University of Sydney, Australia Michael Williams, University of Melbourne, Australia
Language Editors Pete Campbell, St. Vincent’s Institute of Medical Research, Australia Ryan Farr, University of Sydney, Australia Caroline Taylor, O’Brien Institute, Australia
Publisher DE GRUYTER Poland Bogumiła Zuga 32A Str. 01-811 Warsaw, Poland T: +48 22 701 50 15